HVMNE, a novel lymphocryptovirus related to Epstein-Barr virus, induces lymphoma in New Zealand White rabbits

Blood

Volumn 98, Issue 7, 2001, Pages 2193-2199

  Ferrari, Maria G ^a,b,c   Rivadeneira, Emilia D ^a,b,c   Jarrett, Ruth ^a,b,c   Stevceva, Liljana ^a,b,c   Takemoto, Shigeki ^a,b,c   Markham, Phil ^a,b,c   Franchini, Genoveffa ^a,b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Leukaemia Research Fund Virus Centre   (United Kingdom)

^c ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAT PROTEIN; VIRUS DNA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; DNA SEQUENCE; ELECTROPHORETIC MOBILITY; EPSTEIN BARR VIRUS; HERPES VIRUS; HISTOPATHOLOGY; HVMNE VIRUS; LYMPHOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; VIRUS CARCINOGENESIS; VIRUS ISOLATION;

EID: 0035496940     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.7.2193     Document Type: Article

References (47)

1. Cesarman E, Mesri EA. Virus-associated lymphomas. Curr Opin Oncol. 1999;11:322-332.
2. Gallo RC. The first human retrovirus. Sci Am. 1986;255:88-98.
3. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1964;1:702-703.
4. Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev. 1988;1:300-312.
5. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968; 59:94-101.
6. Hale G, Waldmann H. Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants: CAMPATH users. Blood. 1998;91:3079-3083.
7. zur Hausen H, Schulte-Holthausen H, Klein G, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970;228:1056-1058.
8. Epstein MA, Hunt RD, Rabin H. Pilot experiments with EB virus in owl monkey (Aotus trivirgatus), I: reticuloproliferative disease in an inoculated animal. Int J Cancer. 1973;12:309-318.
9. Chapman AL, Rickinson AB. Epstein-Barr virus in Hodgkin's disease. Ann Oncol. 1998;9:S5-S16.
10. Darenkov IA, Marcarelli MA, Basadonna GP, et al. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation. 1997;64:848-852.
11. McDiarmid SV, Jordan S, Kim GS, et al. Prevention and preemptive therapy of postransplant lymphoproiiferative disease in pediatric liver recipients. Transplantation. 1998;66:1604-1611.
12. Kieff E. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. Vol 2. Philadelphia: Lippincott-Raven; 1996:2343-2396.
13. Abe Y, Muta K, Ohshima K, et al. Cytotoxic T-cell lymphoma diffusely involving the entire gastrointestinal tract associated with Epstein-Barr virus and tubercle bacilli infection. Int J Hematol. 2000; 71:379-384.
14. Bonagura VR, Katz BZ, Edwards BL, et al. Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA+ T-cell lymphoma containing linear, EBV DNA. Clin Immunol Immunopathol. 1990;57:32-44.
15. Donadieu J, Canioni D, Cuenod B, et al. A familial T-cell lymphoma with gamma delta phenotype and an original location: possible role of chronic Epstein-Barr virus infection. Cancer. 1996;77: 1571-1577.
16. Dreno B, Celerier P, Fleischmann M, Bureau B, Litoux P. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sézary syndrome. Acta Derm Venereol. 1994;74:355-357.
17. Kanegane H, Bhatia K, Gutierrez M, et al. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood. 1998;91:2085-2091.
18. Millot F, Brizard F, Babin P, et al. t(3;17)(q21;q25) In Epstein-Barr virus associated peripheral T-cell lymphoma: a paediatric case. Br J Haematol. 1998;100:331-334.
19. Minegishi M, Ohashi Y, Tsuchiya S, et al. Disseminated nasal T cell lymphoma with a partial deletion of the LMP1 oncogene in a patient with chronic active Epstein-Barr virus infection. Leukemia. 1995;9:1595-1598.
20. Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT. Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev. 1991;4:129-135.
21. Richei DJ, Lepoutre JM, Kapsenberg JG, et al. Epstein-Barr virus in a CD8-positive T-cell lymphoma. Am J Pathol. 1990;136:1093-1099.
22. Su IJ, Hsieh HC. Clinicopathological spectrum of Epstein-Barr virus-associated T cell malignancies. Leuk Lymphoma. 1992;7:47-53.
23. Suzushima H, Asou N, Fujimoto T, et al. Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. Blood. 1995;85:480-486.
24. + T lymphocytes. Am J Surg Pathol. 1994;18:623-631.
25. Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2. Eur J Immunol. 1992;22:1123-1131.
26. + T lymphocytes. Anticancer Res. 1998;18:3171-3180.
27. Jones JF, Shurin S, Abrarnowsky C, et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med. 1988;318:733-741.
28. Reisman RP, Greco MA. Virus-associated hemophagocytic syndrome due to Epstein-Barr virus. Hum Pathol. 1984;15:290-293.
29. Takeshita M, Akamatsu M, Ohshima K, et al. Angiocentric immunoproliferative lesions of the lymph node. Am J Clin Pathol. 1996;106:69-77.
30. de Bruin PC, Jiwa M, Oudejans JJ, et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood. 1994;83:1612-1618.
31. Iwatsuki K, Ohtsuka M, Harada H, Han G, Kaneke F. Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders. Arch Dermatol. 1997;133: 1081-1086.
32. Slater D. Epstein-Barr virus: an aetiological factor in cutaneous lymphoproliferative disorders? J Pathol. 1991;165:1-4.
33. Mosier DE, Gulizia RJ, Baird SM, et al. Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Microbiol Immunol. 1989;152:195-199.
34. Falk L, Deinhardt F, Nonoyama M, Wolfe C, Bergholz C. Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus. Int J Cancer. 1976;18:798-807.
35. Gerber P, Birch SM. Complement-fixing antibodies in sera of human and non-human primates to viral antigens derived from Burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1967;58:478-484.
36. Gerber P, Pritchett R, Kieff ED. Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus. J Virol. 1976;19:1090-1100.
37. Gerber P, Kalter SS, Schidlovsky G, Peterson WD Jr, Daniel MD, Biologic and antigenic characteristics of Epstein-Barr virus-related herpes-viruses of chimpanzees and baboons. Int J Cancer. 1977;20:448-459.
38. Rivadeneira E, Ferrari MG, Jarrett RF, et al. A novel Epstein-Barr virus-like virus, HV(MNE), in a Macaca nemestrina with mycosis fungoides. Blood. 1999;94:2090-2101.
39. Hayashi K, Koirala TR, Ino H, et al. Malignant lymphoma induction in rabbits by intravenous inoculation of Epstein-Barr virus-related herpesvirus from HTLV-II-transformed cynomolgus leukocyte cell line (Si-IIA). Int J Cancer. 1995;63:872-880.
40. Wutzler P, Meerbach A, Farber I, Wolf H, Scheibner K. Malignant lymphomas induced by an Epstein-Barr virus-related herpesvirus from Macaca arctoides: a rabbit model. Arch Virol. 1995;140: 1979-1995.
41. Rose TM, Strand KB, Schultz ER, et al. Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J Virol. 1997;71:4138-4144.
42. Migone TS, Lin JX, Cereseto A, et al. Constitutively activated JAK-STAT pathway in T-cells transformed with HTLV-I. Science. 1995;269:79-81.
43. Weber-Nordt RM, Egen C, Wehinger J, et al. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood. 1996;88:809-816.
44. Xu X, Kang SH, Heidenrich O, Okerholm M, O'Shea JJ, Nerenberg MI. Constitutive activation of different Jak tyrosine kinases in human T-cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J Clin Invest. 1995;96: 1548-1555.
45. Li SL, Biberfeld P, Ernberg I. DNA of lymphoma-associated herpesvirus (HVMF1) in SIV-infected monkeys (Macaca fascicularis) shows homologies to EBNA-1, -2 and -5 genes. Int J Cancer. 1994;59:287-295.
46. Ramer JC, Garber RL, Steele KE, Boyson JF, O'Rourke C, Thomson JA. Fatal lymphoproliferative disease associated with a novel gamma herpesvirus in a captive population of common marmosets. Lab Anim Sci. 2000;50:59-68.
47. Gires O, Kohlhuber F, Kilger E, et al. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins. EMBO J. 1999;18:3064-3073.